2 "inflammatory bowel diseases" clinical trials found.
-
A Phase 3 Randomized Double-Blind Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Crohn s Disease
This trial is testing an experimental drug tulisokibart (MK-7240) in people with moderately to severely active Crohn’s disease (CD). This trial will compare tulisokibart ... -
EFC18326 - A multicenter multinational randomized double-blind placebo-controlled Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn s Disease
The purpose of this research study is to study an experimental drug SAR447189, also called duvakitug, for the treatment of moderate to severe Crohn’s ...